🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Status
Completed
Location
Hospital Universitario Príncipe de Asturias
Start Date
2020-11-04
Trial ID
NCT04687761
Treatments Being Tested
The study is a multicenter, open label Phase I/II trial. 1. Establish the ...
Status
Completed
Location
UCLA Medical Center, Division of Hematology/Oncology
Start Date
2012-10
Trial ID
NCT02575963
Treatments Being Tested
The purpose of this study is to compare the effectiveness of two multi-agen...
Status
Completed
Location
Stanford University Medical Center
Start Date
2002-08
Trial ID
NCT00136084
This phase I/II trial studies the side effects and best dose of milademetan...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2018-12-17
Trial ID
NCT03634228
Treatments Being Tested
The first goal of this clinical research study is to find the highest safe ...
Status
Completed
Location
M. D. Anderson Cancer Center
Start Date
2010-06
Trial ID
NCT01159028
Treatments Being Tested
Multicenter, randomized, open-label, parallel-group study of guadecitabine ...
Status
Completed
Location
University of Southern California
Start Date
2017-03-16
Trial ID
NCT02920008
Treatments Being Tested
The goal of this clinical research study is to learn if omacetaxine given w...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-07
Trial ID
NCT01272245
Treatments Being Tested
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells which per...
Status
Completed
Location
NHO Nagoya Medical Center /ID# 223671
Start Date
2020-10-05
Trial ID
NCT04509622
Treatments Being Tested
The primary objective of this study is to evaluate if venetoclax when co ad...
Status
Completed
Location
H. Lee Moffit Cancer Center /ID# 164273
Start Date
2017-05-23
Trial ID
NCT03069352
Treatments Being Tested
This phase Ib/II trial finds out the best dose and effect of cladribine and...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-06-11
Trial ID
NCT04848974
Treatments Being Tested